G. Puthenveetil ET AL: "Successful correction of the human -thalassemia major phenotype using a lentiviral vector", Blood, vol. 104, no. 12, 1 December 2004 (2004-12-01), pages 3445-3453, XP055216529, ISSN: 0006-4971, DOI: 10.1182/blood-2004-04-1427 (B1)

WO-A2-98/00541 (B2)

MOSTOSLAVSKY ET AL: "Efficiency of transduction of highly purified murine hematopoietic stem cells by lentiviral and oncoretroviral vectors under conditions of minimal in vitro manipulation", MOLECULAR THERAPY, NATURE PUBLISHING GROUP, GB, vol. 11, no. 6, 1 June 2005 (2005-06-01), pages 932-940, XP005002713, ISSN: 1525-0016, DOI: 10.1016/J.YMTHE.2005.01.005 (B1)

N. Cartier ET AL: "Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy", Science, vol. 326, no. 5954, 6 November 2009 (2009-11-06), pages 818-823, XP055268270, US ISSN: 0036-8075, DOI: 10.1126/science.1171242 (B1)

PAWLIUK R ET AL: "Correction of sickle cell disease in transgenic mouse models of gene therapy", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE, US, vol. 294, 14 December 2001 (2001-12-14), pages 2368-2371, XP002984304, ISSN: 0036-8075, DOI: 10.1126/SCIENCE.1065806 (B1)

PELUS L.M. ET AL.: 'Pleiotropic effects of prostaglandin E2 in hematopoiesis; prostaglandin E2 and other eicosanoids regulate hematopoietic stem and progenitor cell function' PROSTAGLANDINS & OTHER LIPID MEDIATORS vol. 96, 2011, pages 3 - 9, XP028108764 (B1)

US-A1- 2009 092 589 (B1)

WO-A1-2010/054271 (B1)

WO-A2-2004/098531 (B1)

BUCZYNSKI M W et al.: Journal of lipid research, vol. 50, 2009, pages 1015-1038, (B2)

CASE ET AL.: "STABLE TRANSDUCTION OF QUIESCENT CD34+CD38- HUMAN HEMATOPOIETIC CELLS BY HIV-1 BASED LENTIVIRAL VECTORS", PROC. NATL. ACAD. SCI. USA, vol. 96, 1999, pages 2988 - 2993 (B2)

DEMAISON ET AL.: "High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter", HUMAN GENE THERAPY, vol. 13, no. 7, 2002, pages 803 - 813 (B2)

EVERS R: "Transport of glutathione prostaglandin A conjugates by the multidrug resistance protein 1", FEBS Letters, vol. 419, no. 1, 1997, pages 112-116, (B2)

FOLLENZI ET AL.: "Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences", NATURE GENETICS, vol. 25, no. 2, 2000, pages 217 - 222 (B2)

Heffner et al: 2018, Mol. Ther., 26, 1: 320-328 (B2)

NGUYEN ET AL.: "Highly Efficient Lentiviral Vector-Mediated Transduction of Nondividing, fully Reimplantable Primary Hepatocytes", MOLECULAR THERAPY, vol. 6, no. 2, 2002, pages 199 - 209 (B2)

PAUMI C M: "Multidrug Resistance Protein (MRP) 1 and MRP3 Attenuate Cytotoxic and Transactivating Effects of the Cyclopentenone Prostaglandin", Biochemistry, vol. 42, no. 18, 2003, pages 5429-5437, (B2)

Pubchem entry for Thromoxane B2 (from https://pubchem.ncbi.nlm.nih.gov/compound/ thromboxane_B2) (B2)

ROBERSTON ET AL.: "Thromboxane A2 in Vasotonic Angina Pectoris Evidence from Direct Measurements and Inhibitor Trials", NEW ENGLAND JOURNAL OF MEDICINE, vol. 304, no. 17, 1981, pages 998 - 1003 (B2)

SUGIMOTO Y: "Prostaglandin E receptors", Journal of Biological Chemistry, vol. 282, no. 16, 2007, pages 11613-11617, (B2)

SUTTON R.E: "TRANSDUCTION OF HUMAN PROGENITOR HEMATOPOIETIC STEM CELLS BY HUMAN IMMUNODEFICIENCY VIRUS TYPE 1-BASED VECTORS IS CELL CYCLE DEPENDENT", J. of Virol., vol. 73, no. 5, 1999, pages 3649-3660, (B2)

Technical Resource document detailing formulation of Gibco - IMDM (Catalogue Number12440 - Thermofisher Scientific) https://www.thermofisher.com/uk/en/home/te chnical-resources/media/formulation.76.htm l (B2)

UCHIDA ET AL.: "Optimal conditions for lentiviral transduction of engrafting human CD34+ cells", GENE THERAPY., vol. 18, 2011, pages 1078 - 1086 (B2)

Uchida et al. Journal of Virology, Oct. 2009, p 9854-9862 (B2)

Ueno et al: Advances in Prostaglandin, Thromboxane and Leukotriene Research 17:151-154, 1987 (B2)

WAART ET AL.: "Multidrug resistance associated protein 2 mediates transport of prostaglandin E2", LIVER INTERNATIONAL, vol. 26, 2006, pages 362 - 368 (B2)

WO-A1-2013/049615 (B2)

WO-A2-2007/112084 (B2)

GOESSLING W. ET AL.: 'Prostaglandin E2 enhances human cord blood stem cell xenotransplants and shows long-term safety in preclinical nonhuman primate transplant models' CELL STEM CELL vol. 8, 08 April 2011, pages 445 - 458, XP055002056 (B1)